Activation of ErbB2-ErbB3 signaling pathway supports potential therapeutic activity of ErbB inhibitors in AT/RT

被引：8

作者：

Sredni, Simone Treiger ^{[1
,2
]}

Patel, Kashyap ^{[1
]}

Costa, Felipe D'Almeida ^{[3
]}

Bonaldo, Maria de Fatima ^{[2
]}

Tomita, Tadanori ^{[1
,2
]}

机构：

[1] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Neurosurg, Chicago, IL 60611 USA

[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[3] AC Camargo Canc Ctr, Sao Paulo, Brazil

来源：

JOURNAL OF NEURO-ONCOLOGY | 2014年 / 118卷 / 01期

关键词：

REFRACTORY CNS MALIGNANCIES; BRAIN-TUMOR CONSORTIUM; LAPATINIB; CHILDREN; TRIAL;

D O I：

10.1007/s11060-014-1406-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：201 / 203

页数：3

共 3 条

[1] A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study [J].

Fouladi, Maryam ;

Stewart, Clinton F. ;

Blaney, Susan M. ;

Onar-Thomas, Arzu ;

Schaiquevich, Paula ;

Packer, Roger J. ;

Goldman, Stewart ;

Geyer, J. Russell ;

Gajjar, Amar ;

Kun, Larry E. ;

Boyett, James M. ;

Gilbertson, Richard J. .

JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (02) :173-179

[2] Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study [J].

Fouladi, Maryam ;

Stewart, Clinton. F. ;

Blaney, Susan M. ;

Onar-Thomas, Arzu ;

Schaiquevich, Paula ;

Packer, Roger J. ;

Gajjar, Amar ;

Kun, Larry E. ;

Boyett, James M. ;

Gilbertson, Richard J. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) :4221-4227

[3] Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR-ErbB2 signaling with lapatinib [J].

Singh, Anjali ;

Lun, Xueqing ;

Jayanthan, Aarthi ;

Obaid, Halah ;

Ruan, Yibing ;

Strother, Douglas ;

Chi, Susan N. ;

Smith, Amy ;

Forsyth, Peter ;

Narendran, Aru .

MOLECULAR ONCOLOGY, 2013, 7 (03) :497-512

← 1 →